In a filing, Lexaria Bioscience Corp revealed its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25. In the deal valued at $0.92 per share,15,600 shares were bought. As a result of this transaction, BUNKA CHRISTOPHER now holds 270,012 shares worth roughly $0.14 million.
Then, BUNKA CHRISTOPHER bought 11,900 shares, generating $10,866 in total proceeds. Upon buying the shares at $0.91, the Director now owns 281,912 shares.
Before that, McKechnie William Edward bought 5,000 shares. Lexaria Bioscience Corp shares valued at $4,532 were divested by the Director at a price of $0.91 per share. As a result of the transaction, McKechnie William Edward now holds 18,191 shares, worth roughly $9641.230000000001.
Price Performance Review of LEXX
On Friday, Lexaria Bioscience Corp [NASDAQ:LEXX] saw its stock fall -5.20% to $0.53. Over the last five days, the stock has lost -22.51%. Lexaria Bioscience Corp shares have fallen nearly -75.87% since the year began. Nevertheless, the stocks have fallen -74.72% over the past one year. While a 52-week high of $2.43 was reached on 01/06/25, a 52-week low of $0.48 was recorded on 12/26/25.
Levels Of Support And Resistance For LEXX Stock
The 24-hour chart illustrates a support level at 0.4782, which if violated will result in even more drops to 0.4256. On the upside, there is a resistance level at 0.5653. A further resistance level may holdings at 0.5998.
How much short interest is there in Lexaria Bioscience Corp?
A steep rise in short interest was recorded in Lexaria Bioscience Corp stocks on 2025-12-15, dropping by 33323.0 shares to a total of 0.62 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.65 million shares. There was a decline of -5.39%, which implies that there is a negative sentiment for the stock.
